Project Introduction

• Name of the project

1. Shanghai Medicinal Inner-Plant High-tech Industrialization Project

• Project Unit: Shanghai Aisi High-tech Development Co., Ltd

1. The company is founded in 1998 with the registered capital of 13,050,000 RMB. It is a professional company concentrated on application technology research, exploitation, production and sales of figure anamnesis alloy and other new products.

• Project Background

1. Medicinal inner-plant takes the very important role in the clinical application of regeneration medicine and also the integration of material engineering, biological engineering and mechanical engineering, necessary to research and production. China’s government supports the industrialization of medicinal inner-plant. Shanghai has listed it on the importantly supported items in 2005.
   
2. This project manufactures series of artificial arthrosis and limb according to international standard, by good use of the platform of digital technology. It adopts the tender technology, which becomes the model in the field of China’s advanced manufacture technology.

• Main Products and Market Analysis

1. Main products includes custom-built artificial arthrosis and limp, standard artificial arthrosis and spine and figure anamnesis alloy equipment. In 2005, the demand of china’s medical equipment is on increase and the number will over 60 billion RMB.

• Operation and Management

1. Management Group
     General manger has rich management experiences and has been vice president of Sichuan province international Finance Group, general manager of biological and pharmaceutical company, general manager of shanghai Jiaoda biological and pharmaceutical company, president of Shanghai Onlly Huifeng Medical and Pharmaceutical Co., Ltd. Medical majordomo owns the technical share and he is academician of China Engineering Institution, professor of shanghai No.2 Medical University, president of shanghai No. 9 People Hospital clinical medical college, director of shanghai arthrosis surgery clinical medical center and shanghai No. 2 medical University bone and arthrosis research center. Director of artificial body medical engineering research center and president of shanghai Jiaoda-No.2 Medical University Inner-Plant research Institution acts as the engineering majordomo of the company.
2. peration Information
      Total sales income is 1055,000 and lost 744,000 in 2003. total sales income was 1,990,000 and total profit was 13,000 in 2004. at present, the company is in good and increase period. In 2005, it will enhance the business efficiency by enlarging the scale and financing.

• Construction Place and Scale

1. It will take 5 months to make construction in Shanghai Zhangjiang National Biology and Medicine Park. The output is custom-built artificial arthrosis 800 sets, standard artificial arthrosis 3000 sets, and figure anamnesis alloy bone products 40,000 pieces every year.
2. The Sum of Financing: 17000,000 RMB
3. Financial Forecast
   1. Sales income: 43,000,000/year
   2. Taxes: 8,000,000/year
4. Net profit: 16,610,000/year